Brief: Terns Pharmaceuticals Says Mark Vignola To Leave Co Following New CFO Appointment

Terns Pharmaceuticals

29/07/2024 21:27

July 29 (Reuters) - Terns Pharmaceuticals Inc  TERN.O :
    * TERNS PHARMACEUTICALS APPOINTS BIOTECH EXECUTIVE ELONA
KOGAN AS
CHIEF LEGAL OFFICER AND ANNOUNCES UPCOMING CFO TRANSITION
    * TERNS PHARMACEUTICALS INC - MARK VIGNOLA TO LEAVE CO
FOLLOWING
NEW CFO APPOINTMENT
    * TERNS PHARMACEUTICALS INC: VIGNOLA TO CONTINUE AS CFO
THROUGH
END OF JAN 2025, OR UNTIL SUCCESSOR IS FOUND

Source text for Eikon:  ID:nGNXbJH7bt 
Further company coverage:  TERN.O 

 ((Reuters.Briefs@thomsonreuters.com;))